Literature DB >> 20729207

Binding of Toxoplasma gondii glycosylphosphatidylinositols to galectin-3 is required for their recognition by macrophages.

Françoise Debierre-Grockiego1, Sebastian Niehus, Bernadette Coddeville, Elisabeth Elass, Françoise Poirier, Ralf Weingart, Richard R Schmidt, Joël Mazurier, Yann Guérardel, Ralph T Schwarz.   

Abstract

We showed that the production of tumor necrosis factor (TNF) α by macrophages in response to Toxoplasma gondii glycosylphosphatidylinositols (GPIs) requires the expression of both Toll-like receptors TLR2 and TLR4, but not of their co-receptor CD14. Galectin-3 is a β-galactoside-binding protein with immune-regulatory effects, which associates with TLR2. We demonstrate here by using the surface plasmon resonance method that the GPIs of T. gondii bind to human galectin-3 with strong affinity and in a dose-dependent manner. The use of a synthetic glycan and of the lipid moiety cleaved from the GPIs shows that both parts are involved in the interaction with galectin-3. GPIs of T. gondii also bind to galectin-1 but with a lower affinity and only through the lipid moiety. At the cellular level, the production of TNF-α induced by T. gondii GPIs in macrophages depends on the expression of galectin-3 but not of galectin-1. This study is the first identification of a galectin-3 ligand of T. gondii origin, and galectin-3 might be a co-receptor presenting the GPIs to the TLRs on macrophages.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20729207      PMCID: PMC2963347          DOI: 10.1074/jbc.M110.137588

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  X-ray crystal structure of the human galectin-3 carbohydrate recognition domain at 2.1-A resolution.

Authors:  J Seetharaman; A Kanigsberg; R Slaaby; H Leffler; S H Barondes; J M Rini
Journal:  J Biol Chem       Date:  1998-05-22       Impact factor: 5.157

2.  Specific recognition of Candida albicans by macrophages requires galectin-3 to discriminate Saccharomyces cerevisiae and needs association with TLR2 for signaling.

Authors:  Thierry Jouault; Miryam El Abed-El Behi; María Martínez-Esparza; Laetitia Breuilh; Pierre-André Trinel; Mathias Chamaillard; Francois Trottein; Daniel Poulain
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

3.  Fatty acids isolated from Toxoplasma gondii reduce glycosylphosphatidylinositol-induced tumor necrosis factor alpha production through inhibition of the NF-kappaB signaling pathway.

Authors:  Françoise Debierre-Grockiego; Khamran Rabi; Jörg Schmidt; Hildegard Geyer; Rudolf Geyer; Ralph T Schwarz
Journal:  Infect Immun       Date:  2007-03-26       Impact factor: 3.441

4.  The binding of mycolic acids to galectin-3: a novel interaction between a host soluble lectin and trafficking mycobacterial lipids?

Authors:  Erminia Barboni; Stephen Coade; Anna Fiori
Journal:  FEBS Lett       Date:  2005-11-21       Impact factor: 4.124

5.  Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer.

Authors:  Oriol Roda; Elena Ortiz-Zapater; Neus Martínez-Bosch; Ricardo Gutiérrez-Gallego; Miquel Vila-Perelló; Coral Ampurdanés; Hans-Joachim Gabius; Sabine André; David Andreu; Francisco X Real; Pilar Navarro
Journal:  Gastroenterology       Date:  2008-12-13       Impact factor: 22.682

6.  Lack of galectin-3 alters the balance of innate immune cytokines and confers resistance to Rhodococcus equi infection.

Authors:  Luciana C Ferraz; Emerson S Bernardes; Aline F Oliveira; Luciana P Ruas; Marise L Fermino; Sandro G Soares; Adriano M Loyola; Constance Oliver; Maria C Jamur; Daniel K Hsu; Fu-Tong Liu; Roger Chammas; Maria-Cristina Roque-Barreira
Journal:  Eur J Immunol       Date:  2008-10       Impact factor: 5.532

7.  Galectin-3 is a negative regulator of lipopolysaccharide-mediated inflammation.

Authors:  Yubin Li; Mousa Komai-Koma; Derek S Gilchrist; Daniel K Hsu; Fu-Tong Liu; Tabitha Springall; Damo Xu
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

8.  Galectin-3 modulates immune and inflammatory responses during helminthic infection: impact of galectin-3 deficiency on the functions of dendritic cells.

Authors:  Laetitia Breuilh; François Vanhoutte; Josette Fontaine; Caroline M W van Stijn; Isabelle Tillie-Leblond; Monique Capron; Christelle Faveeuw; Thierry Jouault; Irma van Die; Philippe Gosset; François Trottein
Journal:  Infect Immun       Date:  2007-09-04       Impact factor: 3.441

9.  Activation of TLR2 and TLR4 by glycosylphosphatidylinositols derived from Toxoplasma gondii.

Authors:  Françoise Debierre-Grockiego; Marco A Campos; Nahid Azzouz; Jörg Schmidt; Ulrike Bieker; Marianne Garcia Resende; Daniel Santos Mansur; Ralf Weingart; Richard R Schmidt; Douglas T Golenbock; Ricardo T Gazzinelli; Ralph T Schwarz
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

10.  Galectin-1 on cervical epithelial cells is a receptor for the sexually transmitted human parasite Trichomonas vaginalis.

Authors:  Cheryl Y M Okumura; Linda G Baum; Patricia J Johnson
Journal:  Cell Microbiol       Date:  2008-07-10       Impact factor: 3.715

View more
  16 in total

Review 1.  Expanding the universe of cytokines and pattern recognition receptors: galectins and glycans in innate immunity.

Authors:  Juan P Cerliani; Sean R Stowell; Iván D Mascanfroni; Connie M Arthur; Richard D Cummings; Gabriel A Rabinovich
Journal:  J Clin Immunol       Date:  2010-12-24       Impact factor: 8.317

Review 2.  Evolving mechanistic insights into galectin functions.

Authors:  Connie M Arthur; Marcelo Dias Baruffi; Richard D Cummings; Sean R Stowell
Journal:  Methods Mol Biol       Date:  2015

Review 3.  Key regulators of galectin-glycan interactions.

Authors:  Nourine A Kamili; Connie M Arthur; Christian Gerner-Smidt; Eden Tafesse; Anna Blenda; Marcelo Dias-Baruffi; Sean R Stowell
Journal:  Proteomics       Date:  2016-12       Impact factor: 3.984

4.  LPS targets host guanylate-binding proteins to the bacterial outer membrane for non-canonical inflammasome activation.

Authors:  José Carlos Santos; Mathias S Dick; Brice Lagrange; Daniel Degrandi; Klaus Pfeffer; Masahiro Yamamoto; Etienne Meunier; Pawel Pelczar; Thomas Henry; Petr Broz
Journal:  EMBO J       Date:  2018-02-19       Impact factor: 11.598

5.  Galactose recognition by the apicomplexan parasite Toxoplasma gondii.

Authors:  Jan Marchant; Ben Cowper; Yan Liu; Livia Lai; Camila Pinzan; Jean Baptiste Marq; Nikolas Friedrich; Kovilen Sawmynaden; Lloyd Liew; Wengang Chai; Robert A Childs; Savvas Saouros; Peter Simpson; Maria Cristina Roque Barreira; Ten Feizi; Dominique Soldati-Favre; Stephen Matthews
Journal:  J Biol Chem       Date:  2012-03-07       Impact factor: 5.157

6.  CRISPR/Cas9 and glycomics tools for Toxoplasma glycobiology.

Authors:  Elisabet Gas-Pascual; Hiroshi Travis Ichikawa; Mohammed Osman Sheikh; Mariam Isabella Serji; Bowen Deng; Msano Mandalasi; Giulia Bandini; John Samuelson; Lance Wells; Christopher M West
Journal:  J Biol Chem       Date:  2018-11-21       Impact factor: 5.157

Review 7.  Innate immunity against molecular mimicry: Examining galectin-mediated antimicrobial activity.

Authors:  Connie M Arthur; Seema R Patel; Amanda Mener; Nourine A Kamili; Ross M Fasano; Erin Meyer; Annie M Winkler; Martha Sola-Visner; Cassandra D Josephson; Sean R Stowell
Journal:  Bioessays       Date:  2015-12       Impact factor: 4.345

Review 8.  The roles of galectins in parasitic infections.

Authors:  Weikun Shi; Chunyu Xue; Xin-Zhuan Su; Fangli Lu
Journal:  Acta Trop       Date:  2017-10-03       Impact factor: 3.112

9.  Galectin-3 binds Neisseria meningitidis and increases interaction with phagocytic cells.

Authors:  Paola Quattroni; Yanwen Li; Davide Lucchesi; Sebastian Lucas; Derek W Hood; Martin Herrmann; Hans-Joachim Gabius; Christoph M Tang; Rachel M Exley
Journal:  Cell Microbiol       Date:  2012-08-12       Impact factor: 3.715

10.  The Role of TLR2 in Infection and Immunity.

Authors:  Laura Oliveira-Nascimento; Paola Massari; Lee M Wetzler
Journal:  Front Immunol       Date:  2012-04-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.